Journey Medical Corporati... (DERM)
NASDAQ: DERM
· Real-Time Price · USD
7.20
-0.31 (-4.13%)
At close: Sep 24, 2025, 3:59 PM
7.10
-1.39%
After-hours: Sep 24, 2025, 06:19 PM EDT
-4.13% (1D)
| Bid | 7.1 |
| Market Cap | 175.61M |
| Revenue (ttm) | 56.4M |
| Net Income (ttm) | -8.74M |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -19.46 |
| Forward PE | 10.74 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 7.5 |
| Volume | 53,200 |
| Avg. Volume (20D) | 169,909 |
| Open | 7.48 |
| Previous Close | 7.51 |
| Day's Range | 7.15 - 7.53 |
| 52-Week Range | 3.54 - 8.90 |
| Beta | 0.81 |
| Ex-Dividend Date | n/a |
About DERM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DERM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DERM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsJourney Medical Corporation is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+8.51%
Journey Medical shares are trading lower after the...
Unlock content with
Pro Subscription
4 months ago
+18.93%
Journey Medical shares are trading higher after the company reported better-than-expected Q1 financial results.
1 month ago · seekingalpha.com
Journey Medical Corporation (DERM) Q2 2025 Earnings Call TranscriptJourney Medical Corporation (NASDAQ:DERM ) Q2 2025 Earnings Conference Call August 12, 2025 4:30 PM ET Company Participants Claude Maraoui - Founder, President, CEO & Director Jaclyn Jaffe - Senior Di...
